🤝 EBITDA Multiple Calculator

The EV/EBITDA multiple divides enterprise value by EBITDA: how many years of operating earnings the whole firm costs. An enterprise value of $6.8 million on $1.15 million of EBITDA is 5.91x. It is the most quoted valuation multiple in deals because it values the entire firm, debt and equity together, against earnings measured before financing distortions.

How to Use This Calculator

Enter enterprise value and EBITDA to get the multiple, plus a target multiple to see the implied value and the premium or discount to that target. Use it to price acquisitions, benchmark public comps, or sanity-check a DCF.

The Formula

Enterprise value matters because buyers acquire the whole firm including its debt, so equity value alone understates the price. EBITDA matters because it approximates the operating cash the buyer actually gets. The multiple thus answers: how many dollars for each dollar of annual operating earnings, for the entire enterprise.

Worked Example

Enterprise value $6,800,000, EBITDA $1,150,000. Multiple = 6,800,000 / 1,150,000 = 5.91x. At a 6.0x target multiple, implied EV is $6,900,000, so the deal prices at a 1.5 percent discount to target. If EBITDA were overstated by $150,000 of dubious add-backs, the true multiple on $1,000,000 of clean EBITDA would be 6.80x, a full turn higher. Multiple analysis is only as honest as the EBITDA beneath it.

Typical Multiples

Multiple vs DCF

Multiples are fast and market-grounded but circular: they tell you what others paid, not what something is worth. DCF is fundamental but assumption-heavy. Professionals use both: multiples to triangulate the DCF, DCF to sanity-check the multiple. When they disagree sharply, the disagreement is the interesting part. A 5.9x multiple on a DCF that says 9x means either the market is wrong or your forecast is; figure out which before bidding.

Also mind the EBITDA quality behind the multiple. Two companies at 7x are not equally priced if one's EBITDA needs twice the maintenance capex of the other. Capital intensity, growth, and working capital needs all justify multiple differentials, which is why the best comp sets match on business model, not just industry code.

Common Mistakes

Using equity value instead of enterprise value understates the price for levered companies. Applying public-company multiples to private businesses without a size and liquidity discount overpays systematically. And using peak-cycle EBITDA locks in a low multiple on inflated earnings. Build clean inputs with our EBITDA calculator and enterprise value calculator, and cross-check with our DCF calculator.

Why Control Deals Pay More

Control transactions command premiums over minority trading multiples, typically 20 to 40 percent, for concrete reasons. A buyer who controls the company can change strategy, replace management, cut costs, and redirect cash flows, capturing value a passive shareholder cannot. The premium pays for the right to fix what is broken and the power to realize synergies the market cannot.

Synergies split the premium's justification. Cost synergies, eliminating duplicate headquarters or combining purchasing, are credible and bankable; lenders will fund against them. Revenue synergies, cross-selling and growth acceleration, are promised in every deck and achieved in few. Disciplined buyers pay for cost synergies and treat revenue synergies as upside, while undisciplined buyers pay for both and explain the shortfall later.

For sellers, the lesson is to run a real process. A single-bidder negotiation captures little of the control premium; a competitive auction with three credible buyers captures most of it. The multiple in the headline is set as much by the sale process as by the company's quality, which is why the same EBITDA can fetch 6x in a quiet bilateral and 8x in a contested auction.

Minority Discounts and Marketability

Not every stake commands the headline multiple. Minority interests without control typically trade 15 to 30 percent below control value, the minority discount, and private stakes add a further discount for lack of marketability, since the shares cannot be sold quickly. A business worth 7x EBITDA in a control sale might fairly be valued at 5x for a 10 percent nonvoting stake.

These discounts matter in estate planning, partner buyouts, and ESOP valuations, where the law requires fair market value of the actual interest changing hands, not the whole company. Applying a control multiple to a minority stake overstates value systematically, which is why valuation reports spend pages justifying the discounts. The multiple is only half the answer; the interest being valued is the other half.

Estimates for planning only, not financial advice.